JP2019515040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019515040A5 JP2019515040A5 JP2019510569A JP2019510569A JP2019515040A5 JP 2019515040 A5 JP2019515040 A5 JP 2019515040A5 JP 2019510569 A JP2019510569 A JP 2019510569A JP 2019510569 A JP2019510569 A JP 2019510569A JP 2019515040 A5 JP2019515040 A5 JP 2019515040A5
- Authority
- JP
- Japan
- Prior art keywords
- ophthalmic composition
- composition according
- ophthalmic
- eye
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 28
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 208000009745 Eye Disease Diseases 0.000 claims 3
- 239000006184 cosolvent Substances 0.000 claims 3
- 201000009910 diseases by infectious agent Diseases 0.000 claims 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N Phenethyl alcohol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims 2
- LRJOMUJRLNCICJ-JZYPGELDSA-N Prednisolone acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O LRJOMUJRLNCICJ-JZYPGELDSA-N 0.000 claims 2
- 229960002800 prednisolone acetate Drugs 0.000 claims 2
- 230000002335 preservative Effects 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 claims 1
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 claims 1
- 241000224489 Amoeba Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 229960000686 Benzalkonium Chloride Drugs 0.000 claims 1
- 208000010217 Blepharitis Diseases 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- OSASVXMJTNOKOY-UHFFFAOYSA-N Chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 claims 1
- 229960004926 Chlorobutanol Drugs 0.000 claims 1
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 229960001484 Edetic Acid Drugs 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 206010023332 Keratitis Diseases 0.000 claims 1
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 claims 1
- 229940067107 Phenylethyl Alcohol Drugs 0.000 claims 1
- 229920002057 Pluronic® P 103 Polymers 0.000 claims 1
- 229920001213 Polysorbate 20 Polymers 0.000 claims 1
- 229940068977 Polysorbate 20 Drugs 0.000 claims 1
- 229920001214 Polysorbate 60 Polymers 0.000 claims 1
- 229940068968 Polysorbate 80 Drugs 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N Propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims 1
- 229940075582 Sorbic Acid Drugs 0.000 claims 1
- 229940033663 Thimerosal Drugs 0.000 claims 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L Thiomersal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L disodium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 229960002216 methylparaben Drugs 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 229920001983 poloxamer Polymers 0.000 claims 1
- 229920001993 poloxamer 188 Polymers 0.000 claims 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims 1
- 229940113124 polysorbate 60 Drugs 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims 1
- 229960003415 propylparaben Drugs 0.000 claims 1
- WSWCOQWTEOXDQX-UHFFFAOYSA-N sorbic acid Chemical compound CC=CC=CC(O)=O WSWCOQWTEOXDQX-UHFFFAOYSA-N 0.000 claims 1
- 235000010199 sorbic acid Nutrition 0.000 claims 1
- 239000004334 sorbic acid Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 230000002459 sustained Effects 0.000 claims 1
Claims (19)
- 治療活性剤である二グルコン酸クロルヘキシジンを0.05〜0.5% w/vの量で含み、酢酸プレドニゾロン、および眼科的に許容可能な担体を含む眼科用組成物。
- 当該活性剤が、0.05% w/v〜0.2% w/vの濃度である、請求項1に記載の眼科用組成物。
- 酢酸プレドニゾロンが、約0.025% w/v〜約2.0% w/vの濃度である、請求項1に記載の眼科用組成物。
- 保存剤を更に含む、請求項1に記載の眼科用組成物。
- 保存剤が、塩化ベンザルコニウム、チメロサール、クロロブタノール、メチルパラベン、プロピルパラベン、フェニルエチルアルコール、エデト酸二ナトリウム、もしくはソルビン酸、またはこれらの組み合わせを含む、請求項4に記載の眼科用組成物。
- 共溶媒を更に含む、請求項1に記載の眼科用組成物。
- 共溶媒が、ポリソルベート20、ポリソルベート60、ポリソルベート80、Pluronic F−68、Pluronic F−84 Pluronic P−103、もしくはシクロデキストリン、またはこれらの組み合わせを含む、請求項6に記載の眼科用組成物。
- 共溶媒が、約0.01% w/v〜約2.0% w/vの量で存在する、請求項7に記載の眼科用組成物。
- 粘性剤を更に含む、請求項1に記載の眼科用組成物。
- 粘性剤が、ポリビニルアルコール、ポリビニルピロリドン、メチルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、もしくはヒドロキシプロピルセルロース、またはこれらの組み合わせを含む、請求項9に記載の眼科用組成物。
- 粘性剤が、約0.01% w/v〜約2.0% w/vの量で存在する、請求項10に記載の眼科用組成物。
- 眼科用組成物が、溶液剤、懸濁剤、半液剤、乳剤、軟膏剤、クリーム剤、フォームゲル剤、散剤、または制御放出/持続放出製剤として製剤化されている、請求項1に記載の眼科用組成物。
- 眼疾患または感染症を治療または予防する方法における使用のための、請求項1〜12のいずれか1項に記載の眼科用組成物。
- 眼疾患が、結膜炎、眼瞼炎、または角膜炎から選択される、請求項13に記載の眼科用組成物。
- 眼科用組成物の量が、眼科手術または眼科処置の後の感染症を治療または予防するのに有効である、請求項13に記載の眼科用組成物。
- 眼科用組成物が、局所的に投与される、請求項13に記載の眼科用組成物。
- 眼科用組成物が、眼に、一眼当たり約0.001mg〜約5.0mgの当該活性剤の濃度で投与される、請求項13に記載の眼科用組成物。
- 眼科用組成物が、眼に、一眼当たり約50μL〜約80μLの量で投与される、請求項13に記載の眼科用組成物。
- 眼疾患または感染症が、細菌、マイコバクテリア、真菌、ウイルス、またはアメーバ由来である、請求項13に記載の眼科用組成物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662332789P | 2016-05-06 | 2016-05-06 | |
US62/332,789 | 2016-05-06 | ||
US201662337571P | 2016-05-17 | 2016-05-17 | |
US62/337,571 | 2016-05-17 | ||
PCT/US2017/031211 WO2017192944A1 (en) | 2016-05-06 | 2017-05-05 | Ophthalmic compositions |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2019515040A JP2019515040A (ja) | 2019-06-06 |
JP2019515040A5 true JP2019515040A5 (ja) | 2020-06-11 |
JP6941157B2 JP6941157B2 (ja) | 2021-09-29 |
Family
ID=58709627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019510569A Active JP6941157B2 (ja) | 2016-05-06 | 2017-05-05 | 眼科用組成物 |
Country Status (10)
Country | Link |
---|---|
US (2) | US10610499B2 (ja) |
EP (1) | EP3452093B1 (ja) |
JP (1) | JP6941157B2 (ja) |
CN (1) | CN109715215A (ja) |
AU (1) | AU2017261303B9 (ja) |
BR (2) | BR112018072647A2 (ja) |
CA (1) | CA3022983C (ja) |
DK (1) | DK3452093T3 (ja) |
TW (1) | TWI738774B (ja) |
WO (1) | WO2017192944A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017192944A1 (en) | 2016-05-06 | 2017-11-09 | SaCSh Corp. | Ophthalmic compositions |
AU2020394893A1 (en) * | 2019-12-03 | 2022-06-23 | Ntc S.R.L. | Composition comprising budesonide for ophthalmic use |
US11951087B2 (en) * | 2021-07-27 | 2024-04-09 | Lanny Leo Johnson | Eye wash compositions and methods |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO59572A2 (ja) | 1972-01-29 | 1976-03-15 | ||
AU684115B2 (en) * | 1993-12-27 | 1997-12-04 | Mitsubishi Chemical Corporation | Ophthalmic suspension containing diflupredonate |
JP3781792B2 (ja) * | 1993-12-27 | 2006-05-31 | 千寿製薬株式会社 | ジフルプレドナート含有点眼用懸濁液剤 |
DE69526369T2 (de) * | 1995-01-20 | 2002-11-07 | Wakamoto Pharma Co Ltd | Entzündungshemmende augentropfen |
GB9616208D0 (en) * | 1996-08-01 | 1996-09-11 | Smithkline Beecham Plc | Novel Compounds |
US6218428B1 (en) | 2000-04-28 | 2001-04-17 | Emil Chynn | Ophthalmic composition |
US6872705B2 (en) | 2001-07-13 | 2005-03-29 | Allergan, Inc. | Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions |
US20050234018A1 (en) * | 2004-04-15 | 2005-10-20 | Allergan, Inc. | Drug delivery to the back of the eye |
DE102005046769A1 (de) * | 2005-09-29 | 2007-04-05 | Berlin-Chemie Ag | Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus) |
WO2009006130A2 (en) | 2007-06-28 | 2009-01-08 | Bausch & Lomb Incorporated | Salt free hyaluronate ophthalmic solution |
US20100240624A1 (en) * | 2009-03-17 | 2010-09-23 | Aciex Therapeutics, Inc. | Ophthalmic Formulations of Ketotifen and Methods of Use |
ES2537385T3 (es) | 2009-06-09 | 2015-06-08 | Aurinia Pharmaceuticals Inc. | Sistemas de suministro tópico para uso oftálmico |
US20130165419A1 (en) | 2011-12-21 | 2013-06-27 | Insite Vision Incorporated | Combination anti-inflammatory ophthalmic compositions |
CN102973925A (zh) * | 2012-11-27 | 2013-03-20 | 顾月燕 | 一种促进伤口愈合的组合物的制备方法 |
CA2933065C (en) * | 2013-12-12 | 2021-08-24 | Innovation Technologies, Inc. | Materials and methods for controlling infections |
WO2017192944A1 (en) | 2016-05-06 | 2017-11-09 | SaCSh Corp. | Ophthalmic compositions |
-
2017
- 2017-05-05 WO PCT/US2017/031211 patent/WO2017192944A1/en unknown
- 2017-05-05 BR BR112018072647-8A patent/BR112018072647A2/pt active Search and Examination
- 2017-05-05 JP JP2019510569A patent/JP6941157B2/ja active Active
- 2017-05-05 BR BR122024001664-8A patent/BR122024001664A2/pt unknown
- 2017-05-05 EP EP17723886.2A patent/EP3452093B1/en active Active
- 2017-05-05 US US15/587,764 patent/US10610499B2/en active Active
- 2017-05-05 DK DK17723886.2T patent/DK3452093T3/da active
- 2017-05-05 CA CA3022983A patent/CA3022983C/en active Active
- 2017-05-05 TW TW106114962A patent/TWI738774B/zh active
- 2017-05-05 AU AU2017261303A patent/AU2017261303B9/en active Active
- 2017-05-05 CN CN201780041866.9A patent/CN109715215A/zh active Pending
-
2018
- 2018-01-24 US US15/878,767 patent/US10632083B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6527341B2 (ja) | ポビドンヨード、眼科用組成物のための新規代替保存剤 | |
JP2014516954A5 (ja) | ||
CA2784492C (en) | Non-irritating ophthalmic povidone-iodine compositions | |
JP2020196718A5 (ja) | ||
JP2019515040A5 (ja) | ||
JP2015007136A5 (ja) | ||
JP2019526629A (ja) | 眼科用組成物 | |
JP2005529175A (ja) | 第四級化アンモニウムシクロデキストリン化合物 | |
WO2016171152A1 (ja) | 角膜障害の治療剤、改善剤または予防剤 | |
JP2001097865A (ja) | 眼科用組成物 | |
JP4849288B2 (ja) | 点眼剤及び涙液膜の安定化剤 | |
JP2012006962A (ja) | 眼科用組成物 | |
AU2017235979B2 (en) | Non-irritating ophthalmic povidone-iodine compositions | |
AU2019268200B2 (en) | Povidone iodine, a novel alternative preservative for ophthalmic compositions | |
JPH10330257A (ja) | 眼局所用サイトカイン産生抑制剤 | |
JP6571391B2 (ja) | 水性製剤 | |
JP2006169112A (ja) | オキサゾリジノン誘導体含有眼局所投与用組成物 | |
WO2007099431A2 (en) | An aqueous liquid pharmaceutical compositions of gatifloxacin |